Back

DAKSH PHARMACEUTICALS PRIVATE LIMITED

249, INDUSTRIAL AREA, PHASE 2

Product Categories

Formulations
ACECLOFENAC (100 MG) + PARACETAMOL (500 MG),ALBENDAZOLE (100 MG),AMBROXOL (15 MG) + DEXTROMETHORPHAN (10 MG) + CETIRIZINE (5 MG),AMOXYCILLIN (500 MG) + CLAVULANIC ACID (125 MG),AMOXYCILLIN (NA) + CLAVULANIC ACID (NA),CEFIXIME (400 MG),CEFUROXIME (500 MG),GLIMEPIRIDE (0.5 MG) + METFORMIN (500 MG),GLIMEPIRIDE (1 MG) + METFORMIN (1000 MG),LEVETIRACETAM (100 MG),TELMISARTAN (20 MG)

Company Profile

THE GROUP IS COMMITTED TO DELIVERING HIGH-QUALITY PRODUCTS AND SERVICES PHARMACEUTICAL INDUSTRY, FOCUSING ON AFFORDABILITY, INNOVATION, CUSTOMER SATISFACTION, AND SUSTAINABLE GROWTH.OUR EXTENSIVE RANGE OF PRODUCTS, INCLUDING INJECTABLES, TABLETS, CAPSULES, SYRUP, DRY SYRUP, CREAM, LOTION, PROTEIN POWDER, ETC., CATERING TO VARIOUS SEGMENTS OF HUMAN AND VETERINARY, SUCH AS CARDIOLOGY, DIABETES CARE, NEPHROLOGY, ANTI-BIOTIC, ANTI-INFLAMMATORY, SKIN CARE, GYNAECOLOGICAL, NUTRACEUTICAL, EYE CARE, AND MANY MORE. THE GROUP COMPRISES ONE SUBSIDIARY MANUFACTURING COMPANY (M.SEA), COMMITTED TO PROVIDING QUALITY HEALTHCARE PRODUCTS.